Search results
Johnson & Johnson Is a King of Dividend Safety
Motley Fool via Yahoo Finance· 14 hours agoJohnson & Johnson (NYSE: JNJ) is arguably one of the safest dividend stocks in the world. The healthcare giant generates durable cash flow and has a...
Johnson & Johnson (NYSE:JNJ) is Illinois Municipal Retirement Fund’s 10th Largest Position
ETF DAILY NEWS· 22 hours agoIllinois Municipal Retirement Fund raised its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.4% in the fourth quarter, according ...
Johnson & Johnson's (NYSE:JNJ) Stock Has Shown Weakness Lately But Financial Prospects Look Decent:...
Simply Wall St. via Yahoo Finance· 17 hours agoIt is hard to get excited after looking at Johnson & Johnson's (NYSE:JNJ) recent performance, when...
Schnieders Capital Management LLC Decreases Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 18 hours agoSchnieders Capital Management LLC lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.9% in the 4th quarter, according to the company ...
The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value
GuruFocus.com via Yahoo Finance· 16 hours agoIn this article, we will take a look into Johnson & Johnson's (NYSE:JNJ) DCF analysis, a reliable...
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock...
Benzinga via Yahoo Finance· 11 hours agoThe company is collaborating with Johnson & Johnson’s (NYSE:JNJ) Janssen Pharmaceuticals Inc. The...
Earnings call: Nanobiotix reports progress in solid tumor treatment By Investing.com
Investing.com· 6 hours agoNanobiotix has recently shared their full-year 2023 financial and operating results, emphasizing the...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 6 hours agoA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's...
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters via Yahoo News· 6 hours agoA U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 2 days agoThere are many dividend stocks on the market, but few are as prominent as AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ). These companies have...